Skip to main content

IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy

Louvain-la-Neuve, Belgium, June 10, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for the treatment of cancer, today announced a sponsored research agreement with The University of Texas MD Anderson Cancer Center aimed at advancing health economics evidence generation for proton beam therapy. This research will focus on generating robust clinical and economic evidence to better quantify the value of proton therapy compared with other treatment modalities. The research will be led by Dr. Matthew Ning, MD, MPH, Assistant Professor of Radiation Oncology and Dr. Iakovos Toumazis, Assistant Professor of Health Services Research and co-lead for UT MD Anderson’s Institute for Data Science in Oncology’s decision analytics for health focus...

Continue reading

WISeKey’s SEALCOIN Subsidiary Accelerates Space-Based Blockchain Infrastructure Following Strategic $4 Million Investment Commitment

WISeKey’s SEALCOIN Subsidiary Accelerates Space-Based Blockchain Infrastructure Following Strategic $4 Million Investment Commitment New Funding from The Hashgraph Group and WISeKey Supports Expansion of the QAIT-Powered Space Economy and Next-Generation Satellite Transactions Geneva, Switzerland –June 10, 2026 — WISeKey International Holding Ltd (SIX: WIHN; NASDAQ: WKEY), a global leader in cybersecurity, digital identity and IoT, today announced that its subsidiary SEALCOIN which focuses on decentralized physical internet with DePIN technology and houses the development of the SEALCOIN platform secured $4 million strategic investment, including a $1 million commitment from The Hashgraph Group (THG) and a $3 million commitment from WISeKey, with the objective to accelerate the integration of the SEALCOIN ecosystem into the rapidly emerging...

Continue reading

Apollo Adds Senior Policy and Government Affairs Leaders in Europe

Huw van Steenis to Join as European Economic & Policy Strategist Sarah Jenkins to Join as Head of Government Affairs, Europe LONDON and NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Huw van Steenis will join the firm as a Partner and European Economic & Policy Strategist, and that Sarah Jenkins will join the firm as a Managing Director and Head of Government Affairs for Europe. Both newly created positions start in August and are based in London, Apollo’s European headquarters. Van Steenis has spent more than 25 years in leadership and senior advisory roles for global financial institutions, with a focus on strategy, policy and economic research. He was most recently the Vice Chair of Oliver Wyman, and before that served as a senior advisor to the CEO of UBS as well as to the Bank...

Continue reading

Coop Pank AS consolidated results for May 2026

Coop Pank’s financial results in May 2026:In May, number of the bank’s clients increased by 1,700 and number of active clients increased by 700. By the end of the month number of clients reached 234,500 and number of active clients reached 111,100. Over the year, customer base has grown by 9%. Volume of the bank’s customer deposits increased by 57 million euros in May, reaching 2.15 billion euros by the end of month. Deposits of corporate customers increased by 19 million and deposits of private customers increased by 1 million euros. The volume of deposits attracted from international platforms increased by 37 million euros. Over the year, volume of bank deposits increased by 23%. The bank’s loan portfolio increased by 41 million euros over the month and reached 2.22 billion euros by the end of May. The home loan...

Continue reading

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped. This decision follows an interim analysis by an independent data monitoring committee, which determined that the MOBILIZE study is unlikely to provide sufficient efficacy. No safety signals related to riliprubart were identified as part of this interim analysis. The continuation of other ongoing studies with riliprubart, including the VITALIZE phase 3 study (clinical study identifier: NCT06290141) in IVIg-treated patients with CIDP, will be evaluated accordingly. Sanofi...

Continue reading

TGS Begins First Phase of Major Offshore Seismic Dataset in Equatorial Guinea

Oslo, Norway (10 June, 2026) TGS, a leading provider of energy data and intelligence, today announced the signing of an agreement with the Ministry of Hydrocarbon and Mining Development of the Republic of Equatorial Guinea to create an offshore MegaSurvey, a large-scale multi-client seismic product. The first phase will include the post-stack reprocessing of approximately 27,273 kilometers of 2D seismic data and around 35,000 square kilometers of 3D seismic data, with completion expected in Q3 2026. MegaSurveys are harmonized 3D seismic datasets covering large contiguous areas. They support more confident geological interpretation, improve understanding of structural and stratigraphic frameworks, and help reduce exploration uncertainty. The agreement marks the first phase of a broader plan to create a harmonized and seamless seismic data...

Continue reading

Applied Materials Expands Singapore Manufacturing to Support AI Chip Demand

Applied Materials Tampines Campus in SingaporeApplied Materials Tampines Campus in SingaporeNew state-of-the-art facility strengthens Applied’s global manufacturing and R&D capabilities to drive resilience and scalability Tampines Campus sets a new benchmark for sustainable, intelligent semiconductor equipment productionSINGAPORE and SANTA CLARA, Calif., June 09, 2026 (GLOBE NEWSWIRE) — Applied Materials, Inc., the leader in materials engineering solutions for the semiconductor industry, has expanded its manufacturing and R&D operations in Singapore to support the global build-out of AI infrastructure. The new US$500 million (S$600 million) Tampines Campus more than doubles Applied’s advanced cleanroom capacity in Singapore and strengthens the company’s global manufacturing footprint, which also includes...

Continue reading

ING rolls out global subscription banking model

Multimedia – ING Subscriptions GraphicING Go, ING More, ING Extra, ING MaxING rolls out global subscription banking model ING today announced a new global subscriptions model designed to make daily banking easier and deliver greater value for customers. The approach reflects changing customer expectations, with our research showing a growing demand for simplicity, transparency and benefits that fit everyday life. We’re introducing four plans – ING Go, ING More, ING Extra and ING Max – under one brand across all nine retail markets covering 41 million customers (Netherlands, Belgium, Germany, Spain, Italy, Australia, Poland, Romania, Türkiye). Each subscription plan combines everyday banking with additional features and lifestyle benefits that customers would otherwise arrange separately. The features included in each plan...

Continue reading

Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck...

Continue reading

High Arctic Announces Management Changes

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, June 09, 2026 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (the “Corporation” or “High Arctic”) announces today that Jay Bachman, High Arctic’s Interim Chief Financial Officer, has recently tendered his resignation and his last day at High Arctic will be June 10, 2026. The Corporation has waived Mr. Bachman’s notice period in his employment arrangement to permit him to quickly move on to a new opportunity. Mr. Bachman has been with High Arctic since September 2024 and was instrumental in the transition of the accounting and reporting aspects related to High Arctic’s 2024 carve-out transaction with High Arctic Overseas...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.